French Implant Maker Carmat Pins Hopes on Low Energy Heart
July 5, 2017
(Reuters) – Artificial heart maker Carmat is hoping a more energy-efficient implant and the appointment of a production chief can help it overcome recent failures at the French firm. Carmat won clearance from the French medicines agency to resume an implant trial in May after a suspension following the death of a fifth patient in October. Chief Executive Stephane Piat, who took over in September, told Reuters that lessons from previous failures had been learned and Carmat was tightening its clinical trials procedure.